发明名称 Misuse preventative, controlled release formulation
摘要 Disclosed is a misuse preventative, controlled release composition in the form of a multilayered oral dosage form. A first layer contains a plurality of controlled release microparticles having a pharmaceutically active agent (for example, an opioid analgesic) disposed therein. The second layer, which can be adjacent the first layer comprises a pharmaceutically active agent that can be the same or different from the pharmaceutically active agent in the microparticles in the first layer. The composition further comprises a superabsorbent material (for example, polycarbophil) disposed within the first layer, the second layer, or both the first layer and the second layer. When intact, the pharmaceutically active agent is released from the second layer faster than the pharmaceutically active agent in the first layer. When crushed, either intentionally or accidentally, and exposed to an aqueous medium, the superabsorbent material present swells to encapsulate the micioparticles, which remain substantially intact thereby retarding the release of the pharmaceutically active agent from the composition. Also disclosed is a method of using the misuse preventative, controlled release composition to deliver at least one pharmaceutically active agent to a mammal, for example, a human, in need thereof.
申请公布号 AU2009327312(A1) 申请公布日期 2011.08.04
申请号 AU20090327312 申请日期 2009.12.16
申请人 LABOPHARM EUROPE LIMITED;LABOPHARM INC.;LABOPHARM (BARBADOS) LIMITED 发明人 RAHMOUNI, MILOUD;GERVAIS, SONIA;SANT, VINAYAK;SMITH, DAMON;DUFFAYET, FREDERIC;RUSTOM, SHAMS;EL-JAMMAL, ALI;NDONG, JEAN-MICHEL;BOURSIQUOT, BOBBY-ERNST;BICHARA, ALI
分类号 A61K9/28;A61K9/24;A61K9/30;A61K47/36 主分类号 A61K9/28
代理机构 代理人
主权项
地址